Published on 2 Apr 2024 on Insider Monkey via Yahoo Finance
What Makes Veracyte (VCYT) a Lucrative Investment?
Next Century Growth Investors, LLC, an investment Management Company, released its “Micro-Cap Strategy” fourth-quarter investor letter. A copy of the letter can be downloaded here. The recent surge in the stock market highlights the significance of current macroeconomic indicators and the Fed's outlook on future interest rates. The strategy returned 9.54% (net of fees) compared to 15.63% for the Russell Microcap Growth Index. Over the trailing year, the strategy returned 10.15% compared to 9.10% for the index. In addition, please check the fund’s top five holdings to know its best picks in 2023.
NCG Micro-Cap Strategy featured stocks like Veracyte, Inc. (NASDAQ:VCYT) in the Q4 2023 investor letter. Headquartered in South San Francisco, California, Veracyte, Inc. (NASDAQ:VCYT) is a diagnostics company. On April 1, 2024, Veracyte, Inc. (NASDAQ:VCYT) stock closed at $21.64 per share. One-month return of Veracyte, Inc. (NASDAQ:VCYT) was -9.98%, and its shares lost 6.81% of their value over the last 52 weeks. Veracyte, Inc. (NASDAQ:VCYT) has a market capitalization of $1.553 billion.
NCG Micro-Cap Strategy stated the following regarding Veracyte, Inc. (NASDAQ:VCYT) in its fourth quarter 2023 investor letter: